Clinical Trial

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 68Ga/18F-TATE/JR11/LM3 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various SSTR-related disease patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-14.
Trial Details
NCT Number NCT06690957
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
Enrollment 500 participants
Start Date 2019-02-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-11